Delivery Order SPE2DB20D2014-SPE2DB24FA13U

Award Date 10/18/23
Potential Completion Date 10/19/23
Potential Value $23K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,936.89 fixed-price delivery order is for XULANE 150-35 MCG/DAY PATCH 3S, a medical product related to contraception. The contract has an ultimate completion date of December 20, 2023 and was awarded on December 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,094.94 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This is a $3,501.13 delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract is a firm-fixed price delivery order with a completion date of June 6, 2022. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,159.62 for the supply of XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The award has an ultimate completion date of February 29, 2024, and a Firm Fixed Price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,632.16 fixed-price delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award has an ultimate completion date of May 6, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S. The contract has a ceiling value of $1,613.24 and a completion date of October 19, 2021. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.81, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,582.35 delivery order contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch. The contract has a period of performance that runs through December 1, 2023 and uses a Firm Fixed Price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
This federal contract award, valued at $2,284.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 15, 2023. The award was made without any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order valued at $6,876.63. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FA13U
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $22,789.80 for the supply of XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 19, 2023 and was awarded on October 18, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award was made without any set-aside designation, indicating open competition.

Generated 5/12/25, 10:37 AM